Found 7 matching trials
A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants PHASE1 The purpose of this study is to understand bioequivalence (medicines that m...
Show More Location
Pfizer Clinical Research Unit - New Haven
Learn More & Join Trial
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer PHASE1 OKI-219-101 is a Phase 1a/1b, open-label, multicenter, dose-escalation stud...
Show More Status
Active Not Recruiting
Location
California Cancer Associates for Research and Excellence
Learn More & Join Trial
A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease PHASE1 The purpose of this study to understand how the study medicine atirmociclib...
Show More Location
Floridian Clinical Research
Learn More & Join Trial
Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer PHASE2 A study to investigate camizestrant in combination with atirmociclib in par...
Show More Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer PHASE1 This is an umbrella study evaluating the efficacy and safety of multiple tr...
Show More Learn More & Join Trial
Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants PHASE1 The purpose of this clinical trial is to learn about the dose proportionali...
Show More Location
Pfizer Clinical Research Unit - New Haven
Learn More & Join Trial
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer PHASE1 This is a Phase 1b open-label, 2-part study in 3 treatment groups. The 3 tr...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial